Brief: EPO Grants Patents To Initiator Pharma For Pain Treatment And Oral Formulation
BRIEF-EPO Grants Patents To Initiator Pharma For Pain Treatment And Oral Formulation Aug 19 (Reuters) - Initiator Pharma A/S INIT.ST:
EPO GRANTS TWO NEW PATENTS TO INITIATOR PHARMA FOR PAIN TREATMENT AND ORAL FORMULATION
EP 4 608 400 PATENT FOR PAIN TREATMENT VALID UNTIL 2043
Source text: ID:nMFN8S2cFf
Further company coverage: INIT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Initiator Pharma A/S
See all newsBrief: Initiator Pharma Reports Q2 EBIT Of DKK -9.5 Million
Brief: EPO Grants Patents To Initiator Pharma For Pain Treatment And Oral Formulation
Brief: Initiator Pharma Q1 2026 Operating Loss DKK 11.4 Mln
Brief: Initiator Pharma To Fully Prioritize Pudafensine
Brief: Initiator Pharma Reports Q4 Net Revenue Of DKK 0.00